甲状腺乳头状癌患者单侧慢性腮腺炎的68Ga-DOTA-FAPI-04 PET/CT与18F-FDG PET/CT显像
本病例报告描述一名甲状腺乳头状癌患者,全甲状腺切除及碘治疗后因高甲状腺球蛋白而诊断性放射性碘显像阴性(TENIS综合征)转诊,接受18F-FDG与68Ga-DOTA-FAPI-46 PET/CT转移灶评估与治疗计划。FAPI在右侧腮腺摄取而FDG无摄取,随后行99mTcO4-唾液腺显像,诊断为慢性涎腺炎。
要点
- 甲状腺乳头状癌术后碘治疗后高甲状腺球蛋白而诊断性放射性碘显像阴性者,需考虑TENIS综合征。
- 68Ga-FAPI在右侧腮腺摄取而18F-FDG无摄取,提示慢性涎腺炎可能。
- FAPI摄取可见于炎症及纤维化过程,需结合临床鉴别非肿瘤性摄取。
核心结论
- 68Ga-FAPI放射性示踪剂在核医学中是一种新颖且多用途的工具,因其在癌性和炎症条件下显著上调,尤其在涉及纤维化和感染过程中,显示出在多种情况下的潜在用途。
研究设计与样本
- 本文为病例报告,报告一例甲状腺乳头状癌患者,行全甲状腺切除及碘治疗后因高甲状腺球蛋白而诊断性放射性碘显像阴性(TENIS综合征)转诊。
主要发现
- 患者接受18F-FDG和68Ga-DOTA-FAPI-46 PET/CT显像用于转移灶评估和治疗计划。
- FAPI摄取见于右侧腮腺,而FDG无摄取,随后行99mTcO4-唾液腺显像,诊断为慢性涎腺炎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 68 Ga-FAPI (fibroblast activation protein inhibitor) radiotracer is a novel and versatile tool in nuclear medicine, exhibiting potential for use in various conditions due to its significant upregulation in cancerous and inflammatory conditions, particularly those involving fibrotic and infectious processes. In this report, we present the case of a patient with papillary thyroid carcinoma who underwent total thyroidectomy and iodine therapy. He was referred because of high thyroglobulin despite negative diagnostic radioiodine imaging (TENIS syndrome). The patient underwent 18 F-FDG and 68 Ga-DOTA-FAPI-46 PET/CT imaging for metastatic workup and treatment planning. FAPI uptake was observed in the right parotid gland (with no FDG uptake), prompting a 99m TcO 4- salivary scintigraphy. Subsequently, a diagnosis of chronic sialadenitis was made.
引用
- Roshanravan V, Sadeghi R, Zakavi SR, et al. Unilateral Chronic Parotitis With 68 Ga-DOTA-FAPI-04 PET/CT and 18 F-FDG PET/CT Imaging in a Case of a Patient With Papillary Thyroid Carcinoma. Clin Nucl Med. 2023. PMID: 37756475. doi:10.1097/RLU.0000000000004884
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。